Protagonist Therapeutics Inc (NASDAQ:PTGX)

28.11
Delayed Data
As of Jan 28
 +1.73 / +6.56%
Today’s Change
12.80
Today|||52-Week Range
50.54
-17.81%
Year-to-Date
No recent news for Protagonist Therapeutics Inc.

Today’s Trading

Previous close26.38
Today’s open26.01
Day’s range26.01 - 28.15
Volume46,218
Average volume (3 months)1,357,730
Market cap$1.4B
Data as of 4:00pm ET, 01/28/2022

Growth & Valuation

Earnings growth (last year)+35.48%
Earnings growth (this year)-40.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+12,293.07%
P/E ratioNM
Price/Sales24.22
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.58+4.07%
BCYCBicycle Therapeutics...+1.11+2.40%
NSTGNanoString Technolog...+1.26+4.06%
ALECAlector Inc+0.55+3.90%
Data as of 4:00pm ET, 01/28/2022

Financials

Next reporting dateMarch 9, 2022
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$28.6M
Annual profit (last year)-$66.2M
Net profit margin-231.07%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Newark, California

Forecasts